Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation?

Nature Medicine

Volumn 6, Issue 2, 2000, Pages 133-134

  Glabe, Charles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; DRUG ACCUMULATION; KNOCKOUT GENE; LIFE CYCLE; NEUROFIBRILLARY TANGLE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHORT SURVEY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; HYDROLYSIS; MICE; MICE, KNOCKOUT; NEPRILYSIN;

EID: 0033965730     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/72215     Document Type: Short Survey

References (16)

1. Selkoe, D.J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends. Cell Biol. 8, 447-453 (1998).
2. Burdick, D. et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267, 546-554 (1992).
3. Knauer, M.F. et al. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. USA 89, 7437-7441 ((1992).
4. Vassar, R. et al. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741 (1999).
5. Wolfe, M.S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513-517 (1999).
6. Nordstedt, C. et al. The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J. Biol. Chem.269, 30773-30776 (1994).
7. 42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nature Med. 6, 143-150 (2000).
8. Small, D.H. The amyloid cascade hypothesis debate: emerging consensus on the role of Aβ and amyloid in Alzheimer's disease. The Sixth International Conference on Alzheimer's Disease (Amsterdam, The Netherlands) 5, 301-304, 1998.
9. Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999).
10. Irizarry, M.C. et al. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17, 7053-7059 (1997).
11. Calhoun, M.E. et al. Neuron loss in APP transgenic mice. Nature 395, 755-756 (1998).
12. Yang, A.J. et al. Intracellular Aβ 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J. Biol. Chem. 270, 14786-14792 (1995).
13. Skovronsky, D.M., Doms, R.W. & Lee, V.M. Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture. J. Cell Biol. 141, 1031-1039 (1998).
14. Lee, S.J. et al. A detergent-insoluble membrane compartment contains Aβ in vivo. Nature Med.4, 730-734 (1998).
15. Morishima-Kawashima, M. & Ihara, Y. The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37, 15247-15253 (1998).
16. Welihinda, A.A., Tirasophon, W. & Kaufman, R.J. The cellular response to protein misfolding in the endoplasmic reticulum. Gene Express. 7, 293-300 (1999).